Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0591-3331

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 0591-3331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

FDA Label Image

Bupropion Hydrochloride Er Tablets (Image 2)

Bupropion Hydrochloride Er Tablets (Image 2)
This is a medication guide for BuPROPion Hydrochloride Extended-Release Tablets (XL) with a warning not to use in combination with ZYBAN® or any other medicines containing bupropion hydrochloride. The tablets contain 150mg of the active ingredient and should be taken daily as directed by a physician. It is manufactured by Teva Pharmaceuticals and comes in a bottle of 30 tablets. The lot number and expiration date are printed on the label. Printed medication guides are available on tevausa.com/medguides.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.